Its net sales increased 8 per cent to Rs 1,631 crore for the third quarter from Rs 1,509 crore in the year-ago period, Alembic Pharmaceuticals said in a statement.
Alembic Pharma Q3 net profit rises 48% to Rs 180 crore
You May Also Like
SEC Crypto Enforcement Actions Surged 3,000% to $4.7 Billion in 2024: Report
September 14, 2024
Stablecoin Adoption Is Soaring In Emerging Markets: Castle Island Ventures
September 14, 2024
More From Author
SEC Crypto Enforcement Actions Surged 3,000% to $4.7 Billion in 2024: Report
September 14, 2024
Stablecoin Adoption Is Soaring In Emerging Markets: Castle Island Ventures
September 14, 2024
+ There are no comments
Add yours